Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 22, 2023 Category: Cancer & Oncology Authors: Roberta Caputo Giuseppe Buono Vincenzo Di Lauro Daniela Cianniello Claudia Von Arx Matilde Pensabene Martina Pagliuca Carmen Pacilio Francesca Di Rella Annarita Verrazzo Claudia Martinelli Francesco Nuzzo Michelino De Laurentiis Source Type: research
Effectiveness of crizotinib in patients with ROS1-positive non-small-cell lung cancer: real-world evidence in Japan
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 22, 2023 Category: Cancer & Oncology Authors: Naoyuki Nogami Atsushi Nakamura Naoko Shiraiwa Hironori Kikkawa Birol Emir Robin Wiltshire Masahiro Morise Source Type: research
Association between event-free survival and overall survival in early-stage triple-negative breast cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 21, 2023 Category: Cancer & Oncology Authors: Min Huang Peter A Fasching Amin Haiderali Weiguang Xue Wilbur Pan Vassiliki Karantza Fan Yang James Truscott Yiqiao Xin Joyce O'Shaughnessy Source Type: research
KRASG12C mutation in metastatic colorectal cancer: a new target
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 21, 2023 Category: Cancer & Oncology Authors: Rebecca Ibrahim Khalil Saleh Claude Chahine Rita Khoury Nadine Khalife Axel Lecesne Source Type: research
The MOTION study: a randomized, Phase III study of vimseltinib for the treatment of tenosynovial giant cell tumor
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 18, 2023 Category: Cancer & Oncology Authors: William D Tap Maitreyi G Sharma Marc Vallee Bryan D Smith Matthew L Sherman Rodrigo Ruiz-Soto Michiel van de Sande R Lor Randall Nicholas M Bernthal Hans Gelderblom Source Type: research
Ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor after treatment with imatinib: a plain language summary of the phase 3 INTRIGUE trial
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 18, 2023 Category: Cancer & Oncology Authors: Marina Symcox Robin L Jones Source Type: research
Effect of preoperative peripheral blood platelet volume index on prognosis in patients with invasive breast cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 18, 2023 Category: Cancer & Oncology Authors: Kai Huang Suosu Wei Zhen Huang Yujie Xie Chunyu Wei Jinan Xu Lingguang Dong Quanqing Zou Jianrong Yang Source Type: research
A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 17, 2023 Category: Cancer & Oncology Authors: Alexander Spira Nicolas Girard Matthew Krebs Keunchil Park Catherine Shu Lindsay Dougherty Byoung Chul Cho Source Type: research
Systematic review of time to subsequent therapy as a candidate surrogate endpoint in advanced solid tumors
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 17, 2023 Category: Cancer & Oncology Authors: Paul Agapow Rob Mulla Natasha Markuzon Lone H Ottesen Didier Meulendijks Source Type: research
Phase II biomarker identification study of anti-VEGF agents with FOLFIRI for pretreated metastatic colorectal cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 16, 2023 Category: Cancer & Oncology Authors: Tadayoshi Hashimoto Satoshi Otsu Shuichi Hironaka Atsuo Takashima Junki Mizusawa Tomoko Kataoka Haruhiko Fukuda Shunsuke Tsukamoto Tetsuya Hamaguchi Yukihide Kanemitsu Source Type: research
The prognostic value of radiomic features in liver-limited metastatic colorectal cancer patients from the TRIBE2 study
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 14, 2023 Category: Cancer & Oncology Authors: Federica Marmorino Lorenzo Faggioni Daniele Rossini Michela Gabelloni Antonio Goddi Lo ïc Ferrer Veronica Conca Jennifer Vargas Fiammetta Biagiarelli Francesca Daniel Martina Carullo Guglielmo Vetere Cristina Granetto Chiara Boccaccio Dania Cioni Lorenzo Source Type: research
Role of exosomal miRNA-19a/19b and PTEN in brain tumor diagnosis
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 14, 2023 Category: Cancer & Oncology Authors: Nida Sarosh Ashraf Ishrat Mahjabeen Muhammad Zahid Hussain Muhammad Rizwan Maryam Arshad Azhar Mehmood Muhammad Shahbaz Haris Mahmood Akhtar Kayani Source Type: research
Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 14, 2023 Category: Cancer & Oncology Authors: Roxanna Seyedin Julia T Snider Krithika Rajagopalan Sally W Wade Usama Gergis Source Type: research
Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study)
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 14, 2023 Category: Cancer & Oncology Authors: Yusuke Okuma Shogo Nomura Kiichiro Ninomiya Hiroshi Gyotoku Shuji Murakami Yoshihito Kogure Daijiro Harada Kyoichi Okishio Hiroaki Okamoto Yasushi Goto Source Type: research
Plain Language Summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide?
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 10, 2023 Category: Cancer & Oncology Authors: Maha Hussain Cora N Sternberg Eleni Efstathiou Karim Fizazi Qi Shen Xun Lin Jennifer Sugg Joyce Steinberg Bettina Noerby Ugo De Giorgi Neal D Shore Fred Saad Source Type: research
